{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:01:25Z","timestamp":1787994085131,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00198-019-05235-9","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T08:02:53Z","timestamp":1575619373000},"page":"687-697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["COPD as an independent risk factor for osteoporosis and fractures"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-836X","authenticated-orcid":false,"given":"M.G.","family":"Adas-Okuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2669-4245","authenticated-orcid":false,"given":"S.S.","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6061-785X","authenticated-orcid":false,"given":"M.R.","family":"Gazzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Roco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.O.","family":"Pradella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3138-2219","authenticated-orcid":false,"given":"O.A.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.F.","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.H.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7178-8187","authenticated-orcid":false,"given":"J.R.","family":"Jardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-2834","authenticated-orcid":false,"given":"M.","family":"Lazaretti-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"key":"5235_CR1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease - GOLD. https:\/\/goldcopd.org\/. Accessed April 11, 2019"},{"issue":"7","key":"5235_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1513\/pats.200701-004FM","volume":"4","author":"A Agusti","year":"2007","unstructured":"Agusti A (2007) Systemic effects of chronic obstructive pulmonary disease: what we know and what we don\u2019t know (but should). Proc Am Thorac Soc 4(7):522\u2013525. https:\/\/doi.org\/10.1513\/pats.200701-004FM","journal-title":"Proc Am Thorac Soc"},{"issue":"7","key":"5235_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1164\/rccm.201004-0666OC","volume":"183","author":"J Bon","year":"2011","unstructured":"Bon J, Fuhrman CR, Weissfeld JL, Duncan SR, Branch RA, Chang CC, Zhang Y, Leader JK, Gur D, Greenspan SL, Sciurba FC (2011) Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med 183(7):885\u2013890. https:\/\/doi.org\/10.1164\/rccm.201004-0666OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5235_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.arbres.2018.10.010","volume":"55","author":"MR Gazzotti","year":"2019","unstructured":"Gazzotti MR, Roco CM, Pradella CO, Nascimento OA, Porto EF, Adas M, Lazaretti-Castro M, Jardim JR (2019) Frequency of osteoporosis and vertebral fractures in chronic obstructive pulmonary disease (COPD) patients. Arch Bronconeumol 55(5):252\u2013257. https:\/\/doi.org\/10.1016\/j.arbres.2018.10.010","journal-title":"Arch Bronconeumol"},{"issue":"3","key":"5235_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.11005\/jbm.2016.23.3.111","volume":"23","author":"R Okazaki","year":"2016","unstructured":"Okazaki R, Watanabe R, Inoue D (2016) Osteoporosis associated with chronic obstructive pulmonary disease. J Bone Metab 23(3):111\u2013120. https:\/\/doi.org\/10.11005\/jbm.2016.23.3.111","journal-title":"J Bone Metab"},{"issue":"2","key":"5235_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10654-007-9211-5","volume":"23","author":"C de Luise","year":"2008","unstructured":"de Luise C, Brimacombe M, Pedersen L, Sorensen HT (2008) Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study. Eur J Epidemiol 23(2):115\u2013122. https:\/\/doi.org\/10.1007\/s10654-007-9211-5","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"5235_CR7","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/s00198-010-1423-y","volume":"22","author":"NE Morden","year":"2011","unstructured":"Morden NE, Sullivan SD, Bartle B, Lee TA (2011) Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures. Osteoporos Int 22(6):1855\u20131862. https:\/\/doi.org\/10.1007\/s00198-010-1423-y","journal-title":"Osteoporos Int"},{"issue":"6","key":"5235_CR8","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1378\/chest.08-3016","volume":"136","author":"GT Ferguson","year":"2009","unstructured":"Ferguson GT, Calverley PMA, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B (2009) Prevalence and progression of osteoporosis in patients with COPD: results from the towards a revolution in COPD health study. Chest 136(6):1456\u20131465. https:\/\/doi.org\/10.1378\/chest.08-3016","journal-title":"Chest"},{"key":"5235_CR9","unstructured":"Densitometry TISfC Offi cial Positions (2015) ISCD Combined - Official Positions of the International Society for Clinical Densitometry. https:\/\/iscd.app.box.com\/v\/OP-ISCD-2015-Adult. Accessed May 16, 2019"},{"issue":"6","key":"5235_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention D, Therapy","year":"2001","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention D, Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785\u2013795","journal-title":"JAMA"},{"issue":"9","key":"5235_CR11","doi-asserted-by":"publisher","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","volume":"4","author":"TL Kelly","year":"2009","unstructured":"Kelly TL, Wilson KE, Heymsfield SB (2009) Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS One 4(9):e7038. https:\/\/doi.org\/10.1371\/journal.pone.0007038","journal-title":"PLoS One"},{"issue":"3","key":"5235_CR12","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","volume":"152","author":"Standardization of Spirometry","year":"1994","unstructured":"Standardization of Spirometry (1994) Update. American Thoracic Society (1995). Am J Respir Crit Care Med 152(3):1107\u20131136. https:\/\/doi.org\/10.1164\/ajrccm.152.3.7663792","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"5235_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/jbmr.5650110602","volume":"11","author":"HK Genant","year":"1996","unstructured":"Genant HK, Engelke K, Fuerst T, Gluer CC, Grampp S, Harris ST, Jergas M, Lang T, Lu Y, Majumdar S, Mathur A, Takada M (1996) Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 11(6):707\u2013730. https:\/\/doi.org\/10.1002\/jbmr.5650110602","journal-title":"J Bone Miner Res"},{"key":"5235_CR14","unstructured":"R: The R Project for Statistical Computing. https:\/\/www.R-project.org\/. Accessed September 4, 2017"},{"issue":"2","key":"5235_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1378\/chest.121.2.609","volume":"121","author":"DM Biskobing","year":"2002","unstructured":"Biskobing DM (2002) COPD and osteoporosis. Chest 121(2):609\u2013620. https:\/\/doi.org\/10.1378\/chest.121.2.609","journal-title":"Chest"},{"issue":"8","key":"5235_CR16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/gerona\/63.8.867","volume":"63","author":"JD Penrod","year":"2008","unstructured":"Penrod JD, Litke A, Hawkes WG, Magaziner J, Doucette JT, Koval KJ, Silberzweig SB, Egol KA, Siu AL (2008) The association of race, gender, and comorbidity with mortality and function after hip fracture. J Gerontol A Biol Sci Med Sci 63(8):867\u2013872. https:\/\/doi.org\/10.1093\/gerona\/63.8.867","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"5235_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2147\/COPD.S32330","volume":"7","author":"CE Rycroft","year":"2012","unstructured":"Rycroft CE, Heyes A, Lanza L, Becker K (2012) Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis 7:457\u2013494. https:\/\/doi.org\/10.2147\/COPD.S32330","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"5235_CR18","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00198-009-0838-9","volume":"20","author":"R Civitelli","year":"2009","unstructured":"Civitelli R, Armamento-Villareal R, Napoli N (2009) Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int 20(6):843\u2013851. https:\/\/doi.org\/10.1007\/s00198-009-0838-9","journal-title":"Osteoporos Int"},{"issue":"10","key":"5235_CR19","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","volume":"164","author":"ES Siris","year":"2004","unstructured":"Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(10):1108\u20131112. https:\/\/doi.org\/10.1001\/archinte.164.10.1108","journal-title":"Arch Intern Med"},{"issue":"12","key":"5235_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s001980170006","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12(12):989\u2013995. https:\/\/doi.org\/10.1007\/s001980170006","journal-title":"Osteoporos Int"},{"issue":"4","key":"5235_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/BOR.0000000000000304","volume":"28","author":"EV McCloskey","year":"2016","unstructured":"McCloskey EV, Harvey NC, Johansson H, Kanis JA (2016) FRAX updates 2016. Curr Opin Rheumatol 28(4):433\u2013441. https:\/\/doi.org\/10.1097\/BOR.0000000000000304","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"5235_CR22","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-207907","volume":"74","author":"A Marques","year":"2015","unstructured":"Marques A, Ferreira RJ, Santos E, Loza E, Carmona L, da Silva JA (2015) The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1958\u20131967. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207907","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5235_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ecl.2013.09.004","volume":"43","author":"S Kurra","year":"2014","unstructured":"Kurra S, Fink DA, Siris ES (2014) Osteoporosis-associated fracture and diabetes. Endocrinol Metab Clin N Am 43(1):233\u2013243. https:\/\/doi.org\/10.1016\/j.ecl.2013.09.004","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"5235_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00198-013-2504-5","volume":"25","author":"S Nayak","year":"2014","unstructured":"Nayak S, Edwards DL, Saleh AA, Greenspan SL (2014) Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review. Osteoporos Int 25(1):23\u201349. https:\/\/doi.org\/10.1007\/s00198-013-2504-5","journal-title":"Osteoporos Int"},{"issue":"6","key":"5235_CR25","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.bone.2012.02.639","volume":"50","author":"EM Dennison","year":"2012","unstructured":"Dennison EM, Compston JE, Flahive J, Siris ES, Gehlbach SH, Adachi JD, Boonen S, Chapurlat R, Diez-Perez A, Anderson FA Jr, Hooven FH, LaCroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Sambrook P, Silverman S, Watts NB, Greenspan SL, Premaor M, Cooper C, Investigators G (2012) Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone 50(6):1288\u20131293. https:\/\/doi.org\/10.1016\/j.bone.2012.02.639","journal-title":"Bone"},{"issue":"9","key":"5235_CR26","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/jbmr.88","volume":"25","author":"CA Kulak","year":"2010","unstructured":"Kulak CA, Borba VC, Jorgetti V, Dos Reis LM, Liu XS, Kimmel DB, Kulak J Jr, Rabelo LM, Zhou H, Guo XE, Bilezikian JP, Boguszewski CL, Dempster DW (2010) Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease. J Bone Miner Res 25(9):1931\u20131940. https:\/\/doi.org\/10.1002\/jbmr.88","journal-title":"J Bone Miner Res"},{"issue":"3","key":"5235_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s007740050087","volume":"17","author":"H Fujimoto","year":"1999","unstructured":"Fujimoto H, Fujimoto K, Ueda A, Ohata M (1999) Hypoxemia is a risk factor for bone mass loss. J Bone Miner Metab 17(3):211\u2013216","journal-title":"J Bone Miner Metab"},{"key":"5235_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1749-6632.2009.05238.x","volume":"1192","author":"C Wan","year":"2010","unstructured":"Wan C, Shao J, Gilbert SR, Riddle RC, Long F, Johnson RS, Schipani E, Clemens TL (2010) Role of HIF-1alpha in skeletal development. Ann N Y Acad Sci 1192:322\u2013326. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05238.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"5235_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chest.2016.09.001","volume":"151","author":"KJ Dunham-Snary","year":"2017","unstructured":"Dunham-Snary KJ, Wu D, Sykes EA, Thakrar A, Parlow LRG, Mewburn JD, Parlow JL, Archer SL (2017) Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. Chest 151(1):181\u2013192. https:\/\/doi.org\/10.1016\/j.chest.2016.09.001","journal-title":"Chest"},{"issue":"6","key":"5235_CR30","doi-asserted-by":"publisher","first-page":"e65940","DOI":"10.1371\/journal.pone.0065940","volume":"8","author":"D Chen","year":"2013","unstructured":"Chen D, Li Y, Zhou Z, Wu C, Xing Y, Zou X, Tian W, Zhang C (2013) HIF-1alpha inhibits Wnt signaling pathway by activating Sost expression in osteoblasts. PLoS One 8(6):e65940. https:\/\/doi.org\/10.1371\/journal.pone.0065940","journal-title":"PLoS One"},{"issue":"1\u20132","key":"5235_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0303-7207(02)00036-9","volume":"192","author":"JH Park","year":"2002","unstructured":"Park JH, Park BH, Kim HK, Park TS, Baek HS (2002) Hypoxia decreases Runx2\/Cbfa1 expression in human osteoblast-like cells. Mol Cell Endocrinol 192(1\u20132):197\u2013203","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"5235_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10875-009-9286-8","volume":"29","author":"E Sapey","year":"2009","unstructured":"Sapey E, Ahmad A, Bayley D, Newbold P, Snell N, Rugman P, Stockley RA (2009) Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD. J Clin Immunol 29(4):508\u2013516. https:\/\/doi.org\/10.1007\/s10875-009-9286-8","journal-title":"J Clin Immunol"},{"issue":"4 Pt 1","key":"5235_CR33","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1164\/ajrccm.161.4.9903022","volume":"161","author":"N Takabatake","year":"2000","unstructured":"Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, Yuki H, Kato S, Tomoike H (2000) The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161(4 Pt 1):1179\u20131184. https:\/\/doi.org\/10.1164\/ajrccm.161.4.9903022","journal-title":"Am J Respir Crit Care Med"},{"key":"5235_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1465-9921-11-63","volume":"11","author":"F Garcia-Rio","year":"2010","unstructured":"Garcia-Rio F, Miravitlles M, Soriano JB, Munoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J, Committee E-SS (2010) Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 11:63. https:\/\/doi.org\/10.1186\/1465-9921-11-63","journal-title":"Respir Res"},{"key":"5235_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/1465-9921-12-157","volume":"12","author":"P Bai","year":"2011","unstructured":"Bai P, Sun Y, Jin J, Hou J, Li R, Zhang Q, Wang Y (2011) Disturbance of the OPG\/RANK\/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res 12:157. https:\/\/doi.org\/10.1186\/1465-9921-12-157","journal-title":"Respir Res"},{"issue":"11","key":"5235_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.20452\/pamw.4134","volume":"127","author":"C Mathyssen","year":"2017","unstructured":"Mathyssen C, Gayan-Ramirez G, Bouillon R, Janssens W (2017) Vitamin D supplementation in respiratory diseases: evidence from randomized controlled trials. Pol Arch Intern Med 127(11):775\u2013784. https:\/\/doi.org\/10.20452\/pamw.4134","journal-title":"Pol Arch Intern Med"},{"issue":"2","key":"5235_CR37","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/crj.12588","volume":"12","author":"N Kokturk","year":"2018","unstructured":"Kokturk N, Baha A, Oh YM, Young Ju J, Jones PW (2018) Vitamin D deficiency: what does it mean for chronic obstructive pulmonary disease (COPD)? A compherensive review for pulmonologists. Clin Respir J 12(2):382\u2013397. https:\/\/doi.org\/10.1111\/crj.12588","journal-title":"Clin Respir J"},{"key":"5235_CR38","doi-asserted-by":"publisher","first-page":"61\/1","DOI":"10.1590\/2359-3997000000211","volume":"2017","author":"R Nolasco","year":"2017","unstructured":"Nolasco R, Moreira LDF, Bocalin DS, Fronza FCAO, Marin RV, Lazaretti-Castro M (2017) Effects of vitamin D supplementation on pulmonary function in postmenopausal women following an aquatic exercise program. Arch Endocrinol Metab 2017:61\/1. https:\/\/doi.org\/10.1590\/2359-3997000000211","journal-title":"Arch Endocrinol Metab"},{"issue":"8","key":"5235_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1164\/rccm.200612-1749OC","volume":"176","author":"N Zhong","year":"2007","unstructured":"Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, Liu S, Wang X, Wang D, Lu J, Zheng J, Ran P (2007) Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 176(8):753\u2013760. https:\/\/doi.org\/10.1164\/rccm.200612-1749OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5235_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1590\/S1806-37132015000000040","volume":"41","author":"TM Costa","year":"2015","unstructured":"Costa TM, Costa FM, Moreira CA, Rabelo LM, Boguszewski CL, Borba VZ (2015) Sarcopenia in COPD: relationship with COPD severity and prognosis. J Bras Pneumol 41(5):415\u2013421. https:\/\/doi.org\/10.1590\/S1806-37132015000000040","journal-title":"J Bras Pneumol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05235-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05235-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05235-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T00:43:42Z","timestamp":1607129022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05235-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["5235"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05235-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,6]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}